ランキング価格はじめての方へ
  1. 米国企業
  2. CASSAVA SCIENCES INC

CASSAVA SCIENCES INCSAVA

時価総額
$11.7億
PER
サマリーテーブルに戻る
損益計算書バランスシートキャッシュフロー
2011年
12月31日		2012年
12月31日		2013年
12月31日		2014年
12月31日		2015年
12月31日		2016年
12月31日		2017年
12月31日		2018年
12月31日		2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日		2023年
12月31日
Net loss-3-332-12-14-15-12-7-5-6-32-76-97
Net loss-3-332-12-14-15-12-7-5-6-32-76-97
Stock-based compensation5734343211225
Stock-based compensation5734343211225
Depreciation----------0804,0001
Depreciation----------0804,0001
Amortization of intangible assets----------0497,0000
Amortization of Intangible Assets----------0497,0000
Gain on sale of property and equipment---------0---
Prepaid and other assets----------11-1-2
Prepaid and other assets----------11-1-2
Operating lease right-of-use assets and liabilities---------0-000
Operating lease right-of-use assets and liabilities---------0-000
us-gaap_IncreaseDecreaseInAccountsPayable-1-00-01-10-0006-37
us-gaap_IncreaseDecreaseInAccountsPayable-1-00-01-10-0006-37
Accrued development expense------------1
Accrued development expense10-0-11-10-01-02-1-
Accrued compensation and benefits-1-0-0-0-0-0-0-0-002-20
Accrued compensation and benefits-1-0-0-0-0-0-0-0-002-20
Other liabilities-------------0
Other liabilities--------001-0-
Net cash used in operating activities-0-7-----8-5-3-5-30-78-82
Net cash used in operating activities-0-7-----8-5-3-5-30-78-82
Stock-based compensation5734343211225
Stock-based compensation5734343211225
Depreciation----------0804,0001
Depreciation----------0804,0001
Amortization of intangible assets----------0497,0000
Amortization of Intangible Assets----------0497,0000
Gain on sale of property and equipment---------0---
Prepaid and other assets----------11-1-2
Prepaid and other assets----------11-1-2
Operating lease right-of-use assets and liabilities---------0-000
Operating lease right-of-use assets and liabilities---------0-000
us-gaap_IncreaseDecreaseInAccountsPayable-1-00-01-10-0006-37
us-gaap_IncreaseDecreaseInAccountsPayable-1-00-01-10-0006-37
Accrued development expense------------1
Accrued development expense10-0-11-10-01-02-1-
Accrued compensation and benefits-1-0-0-0-0-0-0-0-002-20
Accrued compensation and benefits-1-0-0-0-0-0-0-0-002-20
Other liabilities-------------0
Other liabilities--------001-0-
Net cash used in operating activities-0-7-----8-5-3-5-30-78-82
Purchase of property and equipment---000--0-2230
Net cash used in investing activities6018----2--00-22-3-0
Proceeds from issuance of common stock upon exercise of stock options---------0203
Proceeds from issuance of common stock upon exercise of stock options---------0203
Proceeds from issuance of common stock upon exercise of 2018 warrants--------651--
Proceeds from Warrant Exercises--------651--
Proceeds from common stock offering, net of issuance costs9-010---14--19047-
Proceeds from common stock offering, net of issuance costs9-010---14--19047-
Net cash provided by financing activities9-34-----14675192483
Net cash provided by financing activities9-34-----14675192483
Net (decrease) increase in cash and cash equivalents--------370140-32-80
Purchases of property and equipment included in accounts payable-----------0-
Net loss-3-332-12-14-15-12-7-5-6-32-76-97
Net loss-3-332-12-14-15-12-7-5-6-32-76-97
Stock-based compensation5734343211225
Stock-based compensation5734343211225
Depreciation----------0804,0001
Depreciation----------0804,0001
Amortization of intangible assets----------0497,0000
Amortization of Intangible Assets----------0497,0000
Gain on sale of property and equipment---------0---
Prepaid and other assets----------11-1-2
Prepaid and other assets----------11-1-2
Operating lease right-of-use assets and liabilities---------0-000
Operating lease right-of-use assets and liabilities---------0-000
us-gaap_IncreaseDecreaseInAccountsPayable-1-00-01-10-0006-37
us-gaap_IncreaseDecreaseInAccountsPayable-1-00-01-10-0006-37
Accrued development expense------------1
Accrued development expense10-0-11-10-01-02-1-
Accrued compensation and benefits-1-0-0-0-0-0-0-0-002-20
Accrued compensation and benefits-1-0-0-0-0-0-0-0-002-20
Other liabilities-------------0
Other liabilities--------001-0-
Net cash used in operating activities-0-7-----8-5-3-5-30-78-82
Net cash used in operating activities-0-7-----8-5-3-5-30-78-82
Purchase of property and equipment---000--0-2230
Proceeds from sale of property and equipment---------0---
Net cash used in investing activities6018----2--00-22-3-0
Proceeds from issuance of common stock upon exercise of stock options---------0203
Proceeds from issuance of common stock upon exercise of stock options---------0203
Proceeds from issuance of common stock upon exercise of 2018 warrants--------651--
Proceeds from Warrant Exercises--------651--
Proceeds from common stock offering, net of issuance costs9-010---14--19047-
Proceeds from common stock offering, net of issuance costs9-010---14--19047-
Net cash provided by financing activities9-34-----14675192483
Net cash provided by financing activities9-34-----14675192483
Net (decrease) increase in cash and cash equivalents--------370140-32-80
Net (decrease) increase in cash and cash equivalents--------370140-32-80
Purchases of property and equipment included in accounts payable-----------0-